Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 16, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16,660	12,386	11,793	7,421	7,978	10,181
Market Cap Growth	5.03%	5.03%	58.92%	-6.98%	-21.63%	-2.08%
Enterprise Value	16,543	11,511	11,487	7,314	7,890	10,302
Last Close Price	158.14	117.78	112.36	70.39	75.76	96.40
PE Ratio	19.76	14.69	15.63	10.47	53.05	14.86
PS Ratio	2.06	1.53	1.53	0.99	1.07	1.76
PB Ratio	1.53	1.13	1.18	0.81	0.94	1.23
P/TBV Ratio	1.60	1.19	1.23	0.85	0.98	1.27
P/FCF Ratio	55.82	41.50	15.83	-	12.98	18.56
P/OCF Ratio	15.73	11.70	11.47	21.63	5.89	15.92
EV/Sales Ratio	2.04	1.42	1.49	0.97	1.06	1.79
EV/EBITDA Ratio	13.07	9.42	7.77	6.31	6.77	9.88
EV/EBIT Ratio	17.01	11.83	9.25	7.42	7.79	11.52
EV/FCF Ratio	55.42	38.56	15.42	-	12.83	18.78
Debt / Equity Ratio	0.08	0.08	0.10	0.11	0.13	0.15
Debt / EBITDA Ratio	0.70	0.70	0.66	0.87	0.92	1.14
Debt / FCF Ratio	2.95	2.95	1.34	-	1.78	2.22
Asset Turnover	0.65	0.65	0.65	0.66	0.68	0.55
Inventory Turnover	3.53	3.53	3.62	3.64	3.62	3.90
Quick Ratio	3.45	3.45	3.55	2.38	2.32	2.66
Current Ratio	4.81	4.81	5.15	3.61	3.33	3.76
Return on Equity (ROE)	8.62%	8.62%	8.50%	8.70%	2.76%	9.37%
Return on Assets (ROA)	4.84%	4.84%	6.56%	5.44%	5.79%	5.31%
Return on Capital (ROIC)	5.33%	5.33%	7.32%	6.24%	6.65%	6.12%
Return on Capital Employed (ROCE)	8.60%	8.60%	11.80%	10.20%	11.60%	10.20%
Earnings Yield	5.06%	6.81%	6.40%	9.55%	1.88%	6.73%
FCF Yield	1.79%	2.41%	6.32%	-8.02%	7.71%	5.39%
Dividend Yield	0.32%	0.43%	0.45%	0.71%	0.66%	0.52%
Payout Ratio	6.46%	6.46%	7.15%	7.67%	35.41%	8.10%
Buyback Yield / Dilution	0.04%	0.04%	-0.56%	-0.26%	0.26%	-2.26%
Total Shareholder Return	0.35%	0.46%	-0.12%	0.45%	0.92%	-1.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.